RYCFX Mutual Fund (Rydex Biotechnology Fund Class C) is managed by Rydex Funds with $409,694.29 in net assets. RYCFX expense ratio is 2.38%, holding 75 positions across sectors including Health Care, Unknown, Other. Inception date: 2001-03-30.

RYCFX performance shows a YTD return of 18.35%. The 1-year return is 85.12% and the 5-year return is 12.22%. RYCFX dividend yield stands at 18.37%, paid annually.

RYCFX top holdings include Abbvie Inc (7.4%), Amgen Inc. (5.2%), Gilead Sciences Inc (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). View all RYCFX holdings, sector breakdown, or dividend history.

RYCFX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.